利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

35 条记录 (耗时 0.031 秒)

    Therapeutic Uses for an Aminosterol Compound
    2.
    发明申请
    Therapeutic Uses for an Aminosterol Compound 有权
    氨基甾醇化合物的治疗用途

    公开(公告)号：US20130281419A1

    公开(公告)日：2013-10-24

    申请号：US13673500

    申请日：2012-11-09

    申请人： Michael Zasloff ,  Jon Williams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    发明人： Michael Zasloff ,  Jon Williams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    IPC分类号： A61K31/575

    CPC分类号： A61K31/575 ,  C07J41/0055

    摘要： A pharmaceutical composition includes, as an active ingredient, a compound according to formula 1436 as shown in FIG. 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient. Various pharmaceutical products may be produced including this pharmaceutical composition. Such pharmaceutical products may be used for the treatment of obesity or diabetes. Methods for using the pharmaceutical compositions also are described. In these methods, various diseases are treated or other body functions are activated or inhibited by administering an effective amount of the pharmaceutical composition. For example, diabetes and obesity may be treated by administering an effective amount of the pharmaceutical compositions. Weight gain and growth factor production can be inhibited by administering an effective amount of these pharmaceutical compositions. Appetite can be suppressed by administering an effective amount of the pharmaceutical compositions, and a diuretic effect can be produced.

    摘要翻译： 药物组合物包含作为活性成分的如图14所示的根据式1436的化合物。 1，或其药学上可接受的盐，和药学上可接受的载体或赋形剂。 可以生产包括该药物组合物的各种药物。 这样的药物可以用于治疗肥胖或糖尿病。 还描述了使用药物组合物的方法。 在这些方法中，通过施用有效量的药物组合物来治疗各种疾病或其他身体功能被激活或抑制。 例如，可以通过施用有效量的药物组合物来治疗糖尿病和肥胖症。 通过施用有效量的这些药物组合物可以抑制体重增加和生长因子产生。 可以通过施用有效量的药物组合物来抑制食欲，并且可以产生利尿作用。

    Therapeutic uses for aminosterol compounds
    3.
    发明授权
    Therapeutic uses for aminosterol compounds 有权
    氨基甾醇化合物的治疗用途

    公开(公告)号：US07410959B1

    公开(公告)日：2008-08-12

    申请号：US09885247

    申请日：2000-07-13

    申请人： Michael Zasloff ,  Jon Williams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    发明人： Michael Zasloff ,  Jon Williams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    IPC分类号： A61K31/56 ,  A61K31/555 ,  A01N55/02 ,  C07J41/00

    CPC分类号： A61K31/575 ,  C07J41/0055

    摘要： A pharmaceutical composition includes, as an active ingredient, a compound according to formula 1436 as shown in FIG. 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient. Various pharmaceutical products may be produced including this pharmaceutical composition. Such pharmaceutical products may be used for the treatment of obesity or diabetes. Methods for using the pharmaceutical compositions also are described. In these methods, various diseases are treated or other body functions are activated or inhibited by administering an effective amount of the pharmaceutical composition. For example, diabetes and obesity may be treated by administering an effective amount of the pharmaceutical compositions. Weight gain, and growth factor production can be inhibited by administering an effective amount of these pharmaceutical compositions. Appetite can be suppressed by administering an effective amount of the pharmaceutical compositions, and a diuretic effect can be produced.

    摘要翻译： 药物组合物包含作为活性成分的如图14所示的根据式1436的化合物。 1，或其药学上可接受的盐，和药学上可接受的载体或赋形剂。 可以生产包括该药物组合物的各种药物。 这样的药物可以用于治疗肥胖或糖尿病。 还描述了使用药物组合物的方法。 在这些方法中，通过施用有效量的药物组合物来治疗各种疾病或其他身体功能被激活或抑制。 例如，可以通过施用有效量的药物组合物来治疗糖尿病和肥胖症。 通过施用有效量的这些药物组合物可以抑制体重增加和生长因子产生。 可以通过施用有效量的药物组合物来抑制食欲，并且可以产生利尿作用。

    Therapeutic Uses For Aminosterol Compounds
    4.
    发明申请
    Therapeutic Uses For Aminosterol Compounds 审中-公开
    氨基甾醇化合物的治疗用途

    公开(公告)号：US20080221075A1

    公开(公告)日：2008-09-11

    申请号：US12041440

    申请日：2008-03-03

    申请人： Michael Zasloff ,  Jon Williams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    发明人： Michael Zasloff ,  Jon Williams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    IPC分类号： A61K31/56 ,  C07J41/00 ,  A61P3/04

    CPC分类号： A61K31/575 ,  C07J41/0055

    摘要： A pharmaceutical composition includes, as an active ingredient, a compound according to formula 1436 as shown in FIG. 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient. Various pharmaceutical products may be produced including this pharmaceutical composition. Such pharmaceutical products may be used for the treatment of obesity or diabetes. Methods for using the pharmaceutical compositions also are described. In these methods, various diseases are treated or other body functions are activated or inhibited by administering an effective amount of the pharmaceutical composition. For example, diabetes and obesity may be treated by administering an effective amount of the pharmaceutical compositions. Weight gain, and growth factor production can be inhibited by administering an effective amount of these pharmaceutical compositions. Appetite can be suppressed by administering an effective amount of the pharmaceutical compositions, and a diuretic effect can be produced.

    摘要翻译： 药物组合物包含作为活性成分的如图14所示的根据式1436的化合物。 1，或其药学上可接受的盐，和药学上可接受的载体或赋形剂。 可以生产包括该药物组合物的各种药物。 这样的药物可以用于治疗肥胖或糖尿病。 还描述了使用药物组合物的方法。 在这些方法中，通过施用有效量的药物组合物来治疗各种疾病或其他身体功能被激活或抑制。 例如，可以通过施用有效量的药物组合物来治疗糖尿病和肥胖症。 通过施用有效量的这些药物组合物可以抑制体重增加和生长因子产生。 可以通过施用有效量的药物组合物来抑制食欲，并且可以产生利尿作用。

    Therapeutic Uses for Aminosterol Compounds
    5.
    发明申请
    Therapeutic Uses for Aminosterol Compounds 审中-公开
    氨基甾醇化合物的治疗用途

    公开(公告)号：US20090105204A1

    公开(公告)日：2009-04-23

    申请号：US12254656

    申请日：2008-10-20

    申请人： Michael Zasloff ,  Jon Wiliams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    发明人： Michael Zasloff ,  Jon Wiliams ,  William Kinney ,  Mark Anderson ,  Michael McLane

    IPC分类号： A61K31/575 ,  A61P9/10 ,  A61P3/10 ,  A61P3/04

    CPC分类号： C07J41/0005 ,  A61K31/575

    摘要： A pharmaceutical composition includes, as an active ingredient, a compound according to formula 1436 as shown in FIG. 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient. Various pharmaceutical products may be produced including this pharmaceutical composition. Such pharmaceutical products may be used for the treatment of obesity or diabetes. Methods for using the pharmaceutical compositions also are described. In these methods, various diseases are treated or other body functions are activated or inhibited by administering an effective amount of the pharmaceutical composition. For example, diabetes and obesity may be treated by administering an effective amount of the pharmaceutical compositions. Weight gain, and growth factor production can be inhibited by administering an effective amount of these pharmaceutical compositions. Appetite can be suppressed by administering an effective amount of the pharmaceutical compositions, and a diuretic effect can be produced.

    摘要翻译： 药物组合物包含作为活性成分的如图14所示的根据式1436的化合物。 1，或其药学上可接受的盐，和药学上可接受的载体或赋形剂。 可以生产包括该药物组合物的各种药物。 这样的药物可以用于治疗肥胖或糖尿病。 还描述了使用药物组合物的方法。 在这些方法中，通过施用有效量的药物组合物来治疗各种疾病或其他身体功能被激活或抑制。 例如，可以通过施用有效量的药物组合物来治疗糖尿病和肥胖症。 通过施用有效量的这些药物组合物可以抑制体重增加和生长因子产生。 可以通过施用有效量的药物组合物来抑制食欲，并且可以产生利尿作用。